Intervention

Methylprednisolone

ClinicalTrials.gov intervention label

Clinical trials45
Recruiting4
Common conditions25
Lead sponsors shown15

Clinical trials

45 shown
Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Pediatric Critical AsthmaNCT07455396 · 2026-08-01
RECRUITING
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation ResearchNCT07623668 · 2026-05-28
RECRUITING
MYTHS - MYocarditis THerapy With SteroidsNCT05150704 · 2021-10-07
RECRUITING
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis PlaquesNCT02784210 · 2016-10-05
RECRUITING
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerNCT07852195 · 2027-01-06
NOT_YET_RECRUITING
Nutritional + Usual Corticosteroids Randomized Trial for Immune-Related pneumoniA - Therapeutic Utilization EvaluationNCT07554885 · 2026-04-01
NOT_YET_RECRUITING
Comparison of Corticosteroids vs Placebo on Duration of Ventilatory Support During Severe Acute Exacerbations of COPD Patients in the ICUNCT04163536 · 2021-10-25
UNKNOWN
Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIPNCT05280873 · 2021-10-10
UNKNOWN
Steroid Metabolism in Obese and Non-Obese Pediatric Patients Hospitalized for Status AsthmaticusNCT04874610 · 2021-08-16
COMPLETED
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple SclerosisNCT04688788 · 2021-04-28
ACTIVE_NOT_RECRUITING
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerNCT04666129 · 2021-02-18
COMPLETED
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)NCT04548999 · 2020-12-03
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)NCT04544436 · 2020-11-26
ACTIVE_NOT_RECRUITING
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)NCT04127578 · 2020-01-03
ACTIVE_NOT_RECRUITING
Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCPNCT03978559 · 2019-08-14
UNKNOWN
Methylprednisolone During the Switch Between Natalizumab and FingolimodNCT02769689 · 2019-06-12
UNKNOWN
Imatinib for Multiple Sclerosis (MS) RelapsesNCT03674099 · 2018-10-01
UNKNOWN
Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung CancerNCT03661567 · 2018-08-09
TERMINATED
A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)NCT03387046 · 2018-03-26
TERMINATED
Maximizing Outcome of Multiple Sclerosis TransplantationNCT03342638 · 2017-11-08
TERMINATED
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMTNCT03368664 · 2017-10-23
TERMINATED
A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney TransplantNCT03099122 · 2017-08-16
COMPLETED
Steroid Resistance During COPD Exacerbations With Respiratory FailureNCT03680495 · 2017-07-21
UNKNOWN
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised PatientsNCT02944045 · 2017-02-15
UNKNOWN
Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201NCT02887976 · 2016-09-01
COMPLETED
Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes MellitusNCT03289338 · 2016-06-01
COMPLETED
A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple SclerosisNCT02583594 · 2015-12-06
COMPLETED
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantNCT02061800 · 2013-06-03
UNKNOWN
A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)NCT01390441 · 2011-07-01
TERMINATED
Impact of Intravenous Methylprednisolone Treatment on Blood PressureNCT03590080 · 2011-01-01
COMPLETED
Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast CancerNCT01105650 · 2010-07-01
COMPLETED
Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)NCT01039103 · 2009-12-01
TERMINATED
Pulse ACTH vs. MP for MSNCT01049451 · 2009-11-01
COMPLETED
Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) MethylprednisoloneNCT00947895 · 2009-10-01
TERMINATED
A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or AdalimumabNCT00808210 · 2009-03-05
TERMINATED
Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid ArthritisNCT00634933 · 2008-03-01
TERMINATED
A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to MethotrexateNCT00578305 · 2007-11-01
COMPLETED
Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)NCT01308255 · 2006-09-01
COMPLETED
Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid ArthritisNCT00298272 · 2006-05-01
TERMINATED
A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid ArthritisNCT00299130 · 2005-10-01
COMPLETED
Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)NCT02093026 · 2002-08-01
COMPLETED
Optic Neuritis Treatment Trial (ONTT)NCT00000146 · 1988-07-01
UNKNOWN
Longitudinal Optic Neuritis Study (LONS)NCT00000147 · 1988-07-01
UNKNOWN
The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDSNCT00000741
WITHDRAWN
Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS PatientsNCT00000730
TERMINATED

Common conditions

Multiple Sclerosis10Rheumatoid Arthritis7Optic Neuritis3HIV Infections2Multiple Sclerosis, Relapsing-Remitting2Neoplasms2Pneumonia, Pneumocystis Carinii2Acute Exacerbation of Remitting Relapsing Multiple Sclerosis1Acute Lymphoblastic Leukemia (ALL)1Acute Myelogenous Leukemia (AML)1Arthritis, Rheumatoid1Asthma (Diagnosis)1Asthma in Children1Blood Pressure1Breast Cancer1Charcot Arthropathy1Chronic Myeloid Leukemia (CML)1Chronic Obstructive Pulmonary Disease1Clinically Isolated Syndrome1COPD1COPD Exacerbation1COPD Exacerbation Acute1Diabetes Complications1Drug-Related Side Effects and Adverse Reactions1Emphysema or COPD1

Trial status mix

COMPLETED13
TERMINATED11
UNKNOWN10
ACTIVE_NOT_RECRUITING4
RECRUITING4
NOT_YET_RECRUITING2
WITHDRAWN1

Phase mix

PHASE318
PHASE216
PHASE17
PHASE44
NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.